Spesolimab Speeds Lesion Clearance in Rare Type Of Psoriasis Spesolimab Speeds Lesion Clearance in Rare Type Of Psoriasis
The anti-interleukin 36 receptor monoclonal antibody is under priority review at the Food and Drug Administration for treating GPP flares.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - December 27, 2021 Category: Rheumatology Tags: Dermatology News Source Type: news

Anifrolumab (Saphnelo) Gets Green Light for Approval in EU Anifrolumab (Saphnelo) Gets Green Light for Approval in EU
Anifrolumab, a monoclonal antibody against type I interferon receptor, was approved by the US Food and Drug Administration in July 2021.International Approvals (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - December 18, 2021 Category: Rheumatology Tags: Dermatology News Alert Source Type: news

Tofacitinib Approved for New Ankylosing Spondylitis Indication Tofacitinib Approved for New Ankylosing Spondylitis Indication
The action makes the drug the first Janus kinase (JAK) inhibitor to be approved for ankylosing spondylitis.FDA Approvals (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - December 16, 2021 Category: Rheumatology Tags: Rheumatology News Alert Source Type: news

Low-Dose Rituximab May Keep RA Activity Low in Responders Low-Dose Rituximab May Keep RA Activity Low in Responders
Rituximab doses as low as 200 mg were effective in treating rheumatoid arthritis, an extension study of a small trial in the Netherlands found.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - November 19, 2021 Category: Rheumatology Tags: Rheumatology News Source Type: news

Long-Term Steroids in RA Linked to Increased Cardiovascular Risk Long-Term Steroids in RA Linked to Increased Cardiovascular Risk
Given the range of other therapies now available, avoiding long-term use of glucocorticoids for rheumatoid arthritis can reduce excess risk of heart attack, stroke, or other poor cardiovascular outcomes.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - November 18, 2021 Category: Rheumatology Tags: Rheumatology News Source Type: news

Electronic'Nose' Sniffs Out Sarcoidosis Electronic'Nose' Sniffs Out Sarcoidosis
The e-nose has the potential to generate clinical data not possible through other noninvasive means.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - November 11, 2021 Category: Rheumatology Tags: Pulmonary Medicine News Source Type: news

Lupus in Remission Flares More Often When Reducing, Stopping HCQ Lupus in Remission Flares More Often When Reducing, Stopping HCQ
It's clear that more flares occur when patients in remission or low disease activity stop or reduce hydroxychloroquine, but it's important to consider this effect in different age groups, too.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - November 9, 2021 Category: Rheumatology Tags: Rheumatology News Source Type: news

Abatacept Shows Signal to Delay Onset of Rheumatoid Arthritis Abatacept Shows Signal to Delay Onset of Rheumatoid Arthritis
Early results of a randomized clinical trial show that a 6-month course of abatacept may delay or prevent progression to rheumatoid arthritis.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - November 8, 2021 Category: Rheumatology Tags: Rheumatology News Source Type: news

Risk for VTE in RA May Be Higher With MTX vs Hydroxychloroquine Risk for VTE in RA May Be Higher With MTX vs Hydroxychloroquine
The significance of higher risk for VTE seen among patients with RA who took methotrexate compared with hydroxychloroquine is unclear without researching the relationships between the drugs and VTE.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - November 4, 2021 Category: Rheumatology Tags: Rheumatology News Source Type: news

Acr 2021 acr 2021
Read clinically focused news coverage of key developments from ACR 2021Medscape Rheumatology (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - November 3, 2021 Category: Rheumatology Tags: Rheumatology Conference Coverage Source Type: news

New Study'Changes Understanding of Bone Loss After Menopause'New Study'Changes Understanding of Bone Loss After Menopause '
' Although the average bone loss was 10.1 %...there is a significant variation in the bone loss rate. Women with fast bone loss should receive special attention,'researchers report.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - November 3, 2021 Category: Rheumatology Tags: Diabetes & Endocrinology News Source Type: news

Judge Dismisses Lyme Disease Lawsuit Against IDSA, Doctors Judge Dismisses Lyme Disease Lawsuit Against IDSA, Doctors
The Infectious Diseases Society of America (IDSA) could have chosen to settle the lawsuit instead of fighting it, but the principles at stake were too high, they decided.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - October 25, 2021 Category: Rheumatology Tags: Infectious Diseases News Source Type: news

Lupus May Confer Higher Risk of Death From COVID-19 Lupus May Confer Higher Risk of Death From COVID-19
SLE had a greater impact on mortality and other poor outcomes than all the other comorbidities considered in a cross-sectional study of patients with COVID-19 in Brazil.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - October 14, 2021 Category: Rheumatology Tags: Rheumatology News Source Type: news

LUPUS and CORA 2021 LUPUS and CORA 2021
Read clinically focused news coverage of key developments from LUPUS& CORA 2021.Medscape Rheumatology (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - October 11, 2021 Category: Rheumatology Tags: Rheumatology Conference Coverage Source Type: news

Cut Risedronate Drug Holiday to Under 2 Years in Older Patients Cut Risedronate Drug Holiday to Under 2 Years in Older Patients
Risedronate confers less hip fracture protection than alendronate during drug holidays beyond 2 years, so a 2- to 3-year drug holiday for risedronate is likely too long.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - October 6, 2021 Category: Rheumatology Tags: Diabetes & Endocrinology News Source Type: news

Bone Gains Lost Following Denosumab Stop in Steroid-Treated RA Bone Gains Lost Following Denosumab Stop in Steroid-Treated RA
When denosumab is discontinued, glucocorticoid-treated patients with rheumatoid arthritis need to transition to another osteoporosis therapy.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - September 28, 2021 Category: Rheumatology Tags: Rheumatology News Source Type: news

ACR Updates COVID Vaccine Guidance With Booster Schedule ACR Updates COVID Vaccine Guidance With Booster Schedule
New recommendations advise on the timing of a third vaccine dose for immunocompromised patients, based on current medications and disease activity.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - September 1, 2021 Category: Rheumatology Tags: Rheumatology News Source Type: news

COVID Vax Booster Trial Begun in People With Autoimmune Disease COVID Vax Booster Trial Begun in People With Autoimmune Disease
The trial will investigate the impact of a booster in patients with five autoimmune diseases who are either on or off immunosuppressives.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - August 30, 2021 Category: Rheumatology Tags: Rheumatology News Source Type: news

Bimekizumab Approved in Europe for Psoriasis Treatment Bimekizumab Approved in Europe for Psoriasis Treatment
In the United States, the US Food and Drug Administration is expected to make a decision on approval of bimekizumab for treating psoriasis on October 15.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - August 25, 2021 Category: Rheumatology Tags: Dermatology News Source Type: news

Tocilizumab Shortage Continues as Pandemic Wears On Tocilizumab Shortage Continues as Pandemic Wears On
Emergency use authorization of tocilizumab for COVID-19 has led to a global shortage, but supplies for rheumatoid arthritis and other inflammatory conditions are faring better — for now.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - August 19, 2021 Category: Rheumatology Tags: Rheumatology News Source Type: news

More Rheumatology Patients Are Using Cannabis: Are You Ready? More Rheumatology Patients Are Using Cannabis: Are You Ready?
Karmela Kim Chan, MD, looks at the many unknowns in play regarding the use of and current state of knowledge about medical marijuana and cannabis-derived drugs in patients with rheumatic diseases.Hospital for Special Surgery (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - August 17, 2021 Category: Rheumatology Tags: Rheumatology Commentary Source Type: news

Rheumatologists' Industry Payments Rise; Small Minority Gets Most Rheumatologists' Industry Payments Rise; Small Minority Gets Most
A small percentage of US rheumatologists receive the majority of payments from industry.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - July 16, 2021 Category: Rheumatology Tags: Rheumatology News Source Type: news

Biologic Treatment Mitigates PsA Risk in Patients With Psoriasis, Study Finds Biologic Treatment Mitigates PsA Risk in Patients With Psoriasis, Study Finds
The findings suggest that continued treatment with biologic DMARDs'may reduce the risk of incident PsA in patients with moderate to severe chronic plaque psoriasis. 'Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - June 24, 2021 Category: Rheumatology Tags: Dermatology News Source Type: news

Patients With RA on Rituximab at Risk for Worse COVID Outcomes Patients With RA on Rituximab at Risk for Worse COVID Outcomes
Risk mitigation strategies such as social distancing and wearing masks, especially indoors, remain important for people being treated with rituximab.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - June 8, 2021 Category: Rheumatology Tags: Rheumatology News Source Type: news

EULAR COVID-19 Recommendations Set for Update EULAR COVID-19 Recommendations Set for Update
Conclusions drawn from a systematic literature review largely appear to reinforce the recommendations that have already been made but need further discussion.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - June 3, 2021 Category: Rheumatology Tags: Rheumatology News Source Type: news

Studies Highlight Pandemic's Impact on Patients With RMDs Studies Highlight Pandemic's Impact on Patients With RMDs
From the Europe-based REUMAVID study to the United Kingdom's CONTAIN study, some common themes are emerging, with lessons to be learned for future practice.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - May 7, 2021 Category: Rheumatology Tags: Rheumatology News Source Type: news

Oarsi 2021 oarsi 2021
Read clinically focused news coverage of key developments from OARSI Connect ‘21Medscape Rheumatology (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - May 5, 2021 Category: Rheumatology Tags: Rheumatology Conference Coverage Source Type: news

ANA Testing in a Postpartum Patient at Risk for Dermatomyositis ANA Testing in a Postpartum Patient at Risk for Dermatomyositis
The progression of a 32-year-old woman's dermatomyositis -- a rash that resolved during pregnancy, only to recur postpartum, along with fatigue and weakness.HSS Grand Rounds Complex Cases (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - May 4, 2021 Category: Rheumatology Tags: Rheumatology Clinical Case Source Type: news

At-Home, Remotely Supervised Brain Stimulation Offers Pain Relief At-Home, Remotely Supervised Brain Stimulation Offers Pain Relief
At-home, remotely supervised, transcranial direct-current stimulation effectively relieves pain in older patients with osteoarthritis, a small pilot study suggests.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - April 30, 2021 Category: Rheumatology Tags: Neurology & Neurosurgery News Source Type: news

Rituximab Benefits Seen in Neuropsychiatric Lupus Rituximab Benefits Seen in Neuropsychiatric Lupus
Additionally, the use of concomitant cyclophosphamide might enhance the level of improvement seen in some patients, said Dr Trixy David in presenting data at the British Society for Rheumatology meeting.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - April 30, 2021 Category: Rheumatology Tags: Rheumatology News Source Type: news

Phage-Targeting PCR Test Picks Up Early Lyme Disease Phage-Targeting PCR Test Picks Up Early Lyme Disease
Promising data show that a viral gene in the Lyme disease-causing bacteria can distinguish between early and late infection.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - April 15, 2021 Category: Rheumatology Tags: Infectious Diseases News Source Type: news

Rheumatology Smoking Cessation Referral Program Finds Success Rheumatology Smoking Cessation Referral Program Finds Success
Clinics that adopted a protocolized, EHR-based approach to checking for readiness to quit saw a 26-fold increase in quit-line referrals.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - April 9, 2021 Category: Rheumatology Tags: Rheumatology News Source Type: news

Nearly 20% of Lupus Patients Have Severe Infection in First Decade After Diagnosis Nearly 20% of Lupus Patients Have Severe Infection in First Decade After Diagnosis
Infections remain a leading cause of morbidity and early mortality in patients with SLE, writes Kai Zhao, MSc, of Arthritis Research Canada, Richmond, and colleagues.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - March 12, 2021 Category: Rheumatology Tags: Rheumatology News Source Type: news

RA Experts Highlight Key Developments Over the Past Year RA Experts Highlight Key Developments Over the Past Year
A massive Swedish cohort study suggesting that biologic agents reduce the known excess risk of lymphoma in patients with rheumatoid arthritis was hailed as one of the high points of the last year.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - March 5, 2021 Category: Rheumatology Tags: Rheumatology News Source Type: news

Hepatotoxicity Risk Differs Between Psoriasis, PsA, and RA Patients Hepatotoxicity Risk Differs Between Psoriasis, PsA, and RA Patients
Patients taking methotrexate for psoriasis or psoriatic arthritis were at a higher risk of developing liver disease than were patients with rheumatoid arthritis on methotrexate.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - February 26, 2021 Category: Rheumatology Tags: Rheumatology News Source Type: news

Major Advance in the Treatment of Axial Spondyloarthritis Coming Major Advance in the Treatment of Axial Spondyloarthritis Coming
Rheumatologists can look forward to the likely regulatory approval of the oral Janus kinase inhibitors tofacitinib and upadacitinib for the treatment of axial spondyloarthritis in the first half of 2021.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - February 26, 2021 Category: Rheumatology Tags: Rheumatology News Source Type: news

Checkpoint Inhibitor Safety in Preexisting Autoimmune Diseases Checkpoint Inhibitor Safety in Preexisting Autoimmune Diseases
' To our knowledge, this is the first study to bridge this knowledge gap by presenting'real-world'data on the safety and efficacy of ICI on a national scale,'wrote Monique K. van der Kooij, MD.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - February 17, 2021 Category: Rheumatology Tags: Hematology-Oncology News Source Type: news

Tofacitinib for RA Misses the Mark in Safety Study Tofacitinib for RA Misses the Mark in Safety Study
Daily treatment with tofacitinib led to more malignancies and adverse cardiovascular events in older rheumatoid arthritis patients compared with treatment with a tumor necrosis factor inhibitor.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - February 1, 2021 Category: Rheumatology Tags: Rheumatology News Source Type: news

Drug-Impaired Doctor Sentenced to 20 Years in Prison Drug-Impaired Doctor Sentenced to 20 Years in Prison
A pathologist who misdiagnosed or made errors for more than 3000 patients while intoxicated has been sentenced to 20 years in prison for manslaughter and mail fraud.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - January 26, 2021 Category: Rheumatology Tags: Psychiatry News Source Type: news

Ehlers-Danlos Syndrome Associated With Various Complications Ehlers-Danlos Syndrome Associated With Various Complications
Hospitalized patients with Ehlers-Danlos syndrome (EDS) are more likely to have gastrointestinal, cardiovascular, autonomic, and allergic disorders than are hospitalized patients who do not have EDS.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - January 13, 2021 Category: Rheumatology Tags: Rheumatology News Source Type: news

High HCQ Blood Level May Lower Thrombosis Risk in Lupus High HCQ Blood Level May Lower Thrombosis Risk in Lupus
Studies suggest that it may protect against thrombosis, but the optimal dosing for this purpose remains unknown, wrote Michelle Petri, MD, of Johns Hopkins University, Baltimore, and colleagues.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - January 7, 2021 Category: Rheumatology Tags: Rheumatology News Source Type: news

Osteoporosis Drugs Don't Worsen COVID-19 Risk, May Help Osteoporosis Drugs Don't Worsen COVID-19 Risk, May Help
Observational study supports guidelines advising continuation of osteoporosis medications during COVID-19, and even suggests possible benefit for certain agents.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - November 17, 2020 Category: Rheumatology Tags: Diabetes & Endocrinology News Source Type: news

Update on Antimalarials and Systemic Lupus Erythematosus Update on Antimalarials and Systemic Lupus Erythematosus
A new review provides an update on recent evidence regarding the use of antimalarials in systemic lupus erythematosus.Current Opinion in Rheumatology (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - October 22, 2020 Category: Rheumatology Tags: Rheumatology Journal Article Source Type: news

Low IgA Levels Associated With Infection Risk in SLE Patients Low IgA Levels Associated With Infection Risk in SLE Patients
To the knowledge of first author Ibrahim Almaghlouth, MD,"this is the first dedicated study to examine the relationship between acquired low Igs and infection risk in adult patients with SLE."Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - October 21, 2020 Category: Rheumatology Tags: Rheumatology News Source Type: news

Researchers Home In on Optimal Biopsy Length for Giant Cell Arteritis Researchers Home In on Optimal Biopsy Length for Giant Cell Arteritis
A new retrospective analysis has found 1.5 cm to 2 cm to be the optimal length of a temporal artery biopsy for detecting giant cell arteritis.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - September 1, 2020 Category: Rheumatology Tags: Rheumatology News Source Type: news

Pulmonary Function Tests Not a Good Substitute in ILD Screening Pulmonary Function Tests Not a Good Substitute in ILD Screening
Any screening algorithm should include high-resolution CT, which is good at prognosticating disease, say the authors of a retrospective study of 212 patients with systemic sclerosis.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - July 6, 2020 Category: Rheumatology Tags: Rheumatology News Source Type: news

ACR Issues Guidances for MIS-C and Pediatric Rheumatic Disease ACR Issues Guidances for MIS-C and Pediatric Rheumatic Disease
Two new clinical guidance documents from the American College of Rheumatology provide evidence-based recommendations for   managing pediatric rheumatic disease   during the COVID-19 pandemic.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - June 26, 2020 Category: Rheumatology Tags: Rheumatology News Source Type: news

Some Rheumatic Diseases Tied to Higher Risk of Severe COVID-19 Some Rheumatic Diseases Tied to Higher Risk of Severe COVID-19
Patients with some inflammatory rheumatic conditions are at higher risk for hospital-diagnosed COVID-19 infection compared with the general population, but it depends on the condition and therapy used to treat it, according to a study from Spain.Reuters Health Information (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - June 22, 2020 Category: Rheumatology Tags: Rheumatology News Source Type: news

EULAR Provides COVID-19 Recommendations EULAR Provides COVID-19 Recommendations
The European League Against Rheumatism provisional recommendations for the management of rheumatic and musculoskeletal diseases with COVID-19 concur with guidance already released.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - June 15, 2020 Category: Rheumatology Tags: Rheumatology News Source Type: news

TNF Inhibitors May Dampen COVID-19 Severity TNF Inhibitors May Dampen COVID-19 Severity
Patients on a TNF inhibitor when contracting COVID-19 were less likely to require hospitalization. Conversely, patients on ≥ 10 mg of prednisone daily when infected were more likely to be hospitalized.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - May 21, 2020 Category: Rheumatology Tags: Rheumatology News Source Type: news